X-54440443-G-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_058163.3(TSR2):c.22G>C(p.Ala8Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000185 in 1,127,308 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 54 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_058163.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TSR2 | NM_058163.3 | c.22G>C | p.Ala8Pro | missense_variant | 1/5 | ENST00000375151.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TSR2 | ENST00000375151.5 | c.22G>C | p.Ala8Pro | missense_variant | 1/5 | 1 | NM_058163.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000978 AC: 11AN: 112508Hom.: 0 Cov.: 23 AF XY: 0.000144 AC XY: 5AN XY: 34640
GnomAD3 exomes AF: 0.0000470 AC: 4AN: 85108Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 14726
GnomAD4 exome AF: 0.000194 AC: 197AN: 1014800Hom.: 0 Cov.: 30 AF XY: 0.000153 AC XY: 49AN XY: 319730
GnomAD4 genome AF: 0.0000978 AC: 11AN: 112508Hom.: 0 Cov.: 23 AF XY: 0.000144 AC XY: 5AN XY: 34640
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 09, 2022 | The c.22G>C (p.A8P) alteration is located in exon 1 (coding exon 1) of the TSR2 gene. This alteration results from a G to C substitution at nucleotide position 22, causing the alanine (A) at amino acid position 8 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 03, 2023 | This variant has not been reported in the literature in individuals affected with TSR2-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant  is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 2262503). This variant is present in population databases (rs377577583, gnomAD 0.008%). This sequence change replaces alanine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 8 of the TSR2 protein (p.Ala8Pro). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at